Skip to main content
. 2017 Aug 1;1:PO.17.00018. doi: 10.1200/PO.17.00018

Fig 1.

Fig 1.

Tumor genomic landscape. (A) Frequency of significant findings and uncharacterized/unreported variants of unknown significance (VUSs) in 4,327 point mutations reported in 308 patient tumors, including solid and hematologic malignancies. (B) Frequency of the most commonly observed protein classes in 905 therapeutically targetable VUSs. (C) Frequency of the most commonly observed protein classes in 522 therapeutically targetable, potentially deleterious VUSs.